V
The startup is a biopharmaceutical company focused on commercializing proprietary cannabinoid-based drugs in Brazil and Latin America, with products approved by key regulatory agencies. By providing safe and effective cannabinoid therapies, the company enhances treatment options for doctors and improves patient health outcomes in the region.
Updated 3 months ago
Funding
$8.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup is a biopharmaceutical company focused on commercializing proprietary cannabinoid-based drugs in Brazil and Latin America, with products approved by key regulatory agencies. By providing safe and effective cannabinoid therapies, the company enhances treatment options for doctors and improves patient health outcomes in the region.